AMRX
Amneal Pharmaceuticals Inc
Price:  
8.66 
USD
Volume:  
2,177,318.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Amneal WACC - Weighted Average Cost of Capital

The WACC of Amneal Pharmaceuticals Inc (AMRX) is 9.3%.

The Cost of Equity of Amneal Pharmaceuticals Inc (AMRX) is 10.25%.
The Cost of Debt of Amneal Pharmaceuticals Inc (AMRX) is 11.05%.

Range Selected
Cost of equity 8.80% - 11.70% 10.25%
Tax rate 18.80% - 26.30% 22.55%
Cost of debt 6.50% - 15.60% 11.05%
WACC 7.0% - 11.6% 9.3%
WACC

Amneal WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.08 1.21
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 11.70%
Tax rate 18.80% 26.30%
Debt/Equity ratio 1.03 1.03
Cost of debt 6.50% 15.60%
After-tax WACC 7.0% 11.6%
Selected WACC 9.3%